vs
Aclaris Therapeutics, Inc.（ACRS）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是Aclaris Therapeutics, Inc.的1.4倍（$1.9M vs $1.3M），Rigetti Computing, Inc.同比增速更快（-17.9% vs -85.9%），Rigetti Computing, Inc.自由现金流更多（$-19.5M vs $-47.2M），过去两年Rigetti Computing, Inc.的营收复合增速更高（-21.8% vs -26.5%）
Aclaris Therapeutics是一家处于临床阶段的生物制药企业，专注于研发针对免疫疾病、炎症性疾病和皮肤病的创新靶向疗法，核心管线覆盖斑秃、白癜风等未满足临床需求领域，致力于为全球相关患者提供新型治疗选择。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
ACRS vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.4倍
$1.3M
营收增速更快
RGTI
高出68.1%
-85.9%
自由现金流更多
RGTI
多$27.8M
$-47.2M
两年增速更快
RGTI
近两年复合增速
-26.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3M | $1.9M |
| 净利润 | — | $-18.2M |
| 毛利率 | 58.9% | 34.9% |
| 营业利润率 | — | -1209.7% |
| 净利率 | — | -974.7% |
| 营收同比 | -85.9% | -17.9% |
| 净利润同比 | 79.5% | 88.1% |
| 每股收益（稀释后） | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACRSRGTI
| Q4 25 | $1.3M | $1.9M | ||
| Q3 25 | $3.3M | $1.9M | ||
| Q2 25 | $1.8M | $1.8M | ||
| Q1 25 | $1.5M | $1.5M | ||
| Q4 24 | $9.2M | $2.3M | ||
| Q3 24 | $4.3M | $2.4M | ||
| Q2 24 | $2.8M | $3.1M | ||
| Q1 24 | $2.4M | $3.1M |
净利润ACRSRGTI
| Q4 25 | — | $-18.2M | ||
| Q3 25 | $-14.6M | $-201.0M | ||
| Q2 25 | $-15.4M | $-39.7M | ||
| Q1 25 | $-15.1M | $42.6M | ||
| Q4 24 | $-96.6M | $-153.0M | ||
| Q3 24 | $-7.6M | $-14.8M | ||
| Q2 24 | $-11.0M | $-12.4M | ||
| Q1 24 | $-16.9M | $-20.8M |
毛利率ACRSRGTI
| Q4 25 | 58.9% | 34.9% | ||
| Q3 25 | 83.7% | 20.7% | ||
| Q2 25 | 71.0% | 31.4% | ||
| Q1 25 | 65.2% | 30.0% | ||
| Q4 24 | 92.3% | 44.1% | ||
| Q3 24 | 85.0% | 50.6% | ||
| Q2 24 | 77.4% | 64.5% | ||
| Q1 24 | 66.3% | 49.1% |
营业利润率ACRSRGTI
| Q4 25 | — | -1209.7% | ||
| Q3 25 | -519.8% | -1055.4% | ||
| Q2 25 | -1035.9% | -1103.9% | ||
| Q1 25 | -1242.9% | -1469.6% | ||
| Q4 24 | -1082.3% | -813.3% | ||
| Q3 24 | -240.9% | -729.4% | ||
| Q2 24 | -464.7% | -521.2% | ||
| Q1 24 | -789.4% | -543.4% |
净利率ACRSRGTI
| Q4 25 | — | -974.7% | ||
| Q3 25 | -443.0% | -10321.9% | ||
| Q2 25 | -868.3% | -2201.8% | ||
| Q1 25 | -1036.8% | 2895.3% | ||
| Q4 24 | -1048.3% | -6726.5% | ||
| Q3 24 | -174.6% | -623.8% | ||
| Q2 24 | -397.2% | -402.5% | ||
| Q1 24 | -706.5% | -680.6% |
每股收益（稀释后）ACRSRGTI
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.12 | $-0.62 | ||
| Q2 25 | $-0.13 | $-0.13 | ||
| Q1 25 | $-0.12 | $0.13 | ||
| Q4 24 | $-1.21 | $-0.80 | ||
| Q3 24 | $-0.11 | $-0.08 | ||
| Q2 24 | $-0.15 | $-0.07 | ||
| Q1 24 | $-0.24 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.0M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $103.1M | $546.2M |
| 总资产 | $160.5M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACRSRGTI
| Q4 25 | $20.0M | $44.9M | ||
| Q3 25 | $25.3M | $26.1M | ||
| Q2 25 | $25.4M | $57.2M | ||
| Q1 25 | $30.4M | $37.2M | ||
| Q4 24 | $24.6M | $67.7M | ||
| Q3 24 | $47.7M | $20.3M | ||
| Q2 24 | $22.8M | $20.7M | ||
| Q1 24 | $35.8M | $35.1M |
股东权益ACRSRGTI
| Q4 25 | $103.1M | $546.2M | ||
| Q3 25 | $120.1M | $371.8M | ||
| Q2 25 | $131.7M | $553.3M | ||
| Q1 25 | $144.1M | $207.1M | ||
| Q4 24 | $155.6M | $126.6M | ||
| Q3 24 | $130.2M | $122.8M | ||
| Q2 24 | $133.8M | $122.2M | ||
| Q1 24 | $142.0M | $115.6M |
总资产ACRSRGTI
| Q4 25 | $160.5M | $666.6M | ||
| Q3 25 | $175.5M | $630.3M | ||
| Q2 25 | $189.1M | $636.7M | ||
| Q1 25 | $198.1M | $269.1M | ||
| Q4 24 | $220.3M | $284.8M | ||
| Q3 24 | $182.4M | $157.3M | ||
| Q2 24 | $161.1M | $162.4M | ||
| Q1 24 | $174.1M | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-47.1M | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | $-47.2M | $-19.5M |
| 自由现金流率自由现金流/营收 | -3646.6% | -1042.5% |
| 资本支出强度资本支出/营收 | 8.6% | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-81.3M | $-77.2M |
8季度趋势，按日历期对齐
经营现金流ACRSRGTI
| Q4 25 | $-47.1M | $-14.9M | ||
| Q3 25 | $-10.9M | $-13.8M | ||
| Q2 25 | $-10.0M | $-16.2M | ||
| Q1 25 | $-13.1M | $-13.7M | ||
| Q4 24 | $-8.9M | $-8.5M | ||
| Q3 24 | $22.0M | $-15.4M | ||
| Q2 24 | $-12.3M | $-13.5M | ||
| Q1 24 | $-20.8M | $-13.1M |
自由现金流ACRSRGTI
| Q4 25 | $-47.2M | $-19.5M | ||
| Q3 25 | $-11.0M | $-19.7M | ||
| Q2 25 | $-10.0M | $-21.8M | ||
| Q1 25 | $-13.1M | $-16.2M | ||
| Q4 24 | — | $-9.8M | ||
| Q3 24 | — | $-17.7M | ||
| Q2 24 | $-12.3M | $-15.6M | ||
| Q1 24 | $-20.9M | $-18.6M |
自由现金流率ACRSRGTI
| Q4 25 | -3646.6% | -1042.5% | ||
| Q3 25 | -332.1% | -1012.4% | ||
| Q2 25 | -563.5% | -1212.4% | ||
| Q1 25 | -900.3% | -1100.4% | ||
| Q4 24 | — | -432.1% | ||
| Q3 24 | — | -744.5% | ||
| Q2 24 | -446.0% | -504.3% | ||
| Q1 24 | -873.6% | -610.5% |
资本支出强度ACRSRGTI
| Q4 25 | 8.6% | 244.8% | ||
| Q3 25 | 0.7% | 302.5% | ||
| Q2 25 | 1.2% | 314.7% | ||
| Q1 25 | 3.0% | 173.0% | ||
| Q4 24 | 0.0% | 56.4% | ||
| Q3 24 | 0.0% | 95.8% | ||
| Q2 24 | 0.5% | 66.3% | ||
| Q1 24 | 5.6% | 180.0% |
现金转化率ACRSRGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACRS
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
